Updates are available Correction dated 2021-04-30

Article History

Received: 11 September 2020

Accepted: 7 December 2020

First Online: 3 February 2021

Change Date: 30 April 2021

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s00262-021-02942-3

Compliance with ethical standards

:

: MSK has institutional financial interests related to this research in the form of intellectual property rights and equity interests in Y-mAbs, the company licensing the intellectual property from MSK. Kim Kramer is a consultant and has equity interests in Y-mAbs Therapeutics Inc.

: Patient (proxy) consented to be treated on IRB-approved protocol registered to clinicaltrials.gov NCT00089245.